Gland Pharma stock lose 24% of its value in 3 days. What’s spooking investors?
Shares of fell as much as 24% to Rs 1,681 per share in the last three trading sessions on the BSE after the company reported a fall of 20.14% in consolidated net profit to Rs 241.24 crore due to lower sales and higher expenses. In the second quarter of FY22, the profit after tax (PAT) … Read more